Clinical Trials in Salt Lake City

Showing 12321-12340 of 16,694 trials

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

NCT01117454

The purpose of this study is to test whether the addition of oral flecainide to standard therapy will reduce ventricular ectopy on exercise test compared to placebo plus standard therapy in patients with Catecholaminergic Polymorphic Ventricular Tachycardia.

Catecholaminergic Polymorphic Ventricular Tachycardia

Vanderbilt University Medical Center14 participantsStarted Dec 2011

Los Angeles, California, United States • Orange, California, United States • New York, New York, United States +7 more locations

COMPLETED< 1 mile

Stem Cell Related Donor Safety Study

NCT00948636

The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors. The study will also assess the hypothesis that young (\<18 years) and older (\>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations. An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.

Related Hematopoietic Stem Cell Donors

Center for International Blood and Marrow Transplant Research1,812 participantsStarted Jan 2010

Phoenix, Arizona, United States • San Diego, California, United States • San Francisco, California, United States +49 more locations

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

Stem Cell Related Donor Safety Study

Find Trials by Condition in Salt Lake City

Progressive Strength Training in Spinal Muscular Atrophy

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma

A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS.

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

An Observational Study of Cholesterol in Coronary Arteries

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris

Hyper- and Hypokalemic Periodic Paralysis Study

A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX